“Gemcitabine-based polychemotherapy for advanced pancreatic cancer: Is it ready for prime time? A pooled analysis of 3 682 patients enrolled in 12 phase II trials”. - Millela,M.; Carlini,A. (J Clin Oncol, ASCO Annual Meeting Proceedings Part I, 2006)